RLYB
Rallybio Corp
NASDAQ: RLYB · HEALTHCARE · BIOTECHNOLOGY
$8.98
+1.13% today
Updated 2026-04-30
Market cap
$46.55M
P/E ratio
—
P/S ratio
54.25x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$2 – $11
Volume
0.2M
Rallybio Corp (RLYB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,888.00%
ROE
-15.00%
ROA
-30.10%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-17.63M | — | — | — |
| 2020 | $0.00 | $-26.45M | — | — | — |
| 2021 | $0.00 | $-47.01M | — | — | — |
| 2022 | $0.00 | $-66.65M | — | — | — |
| 2023 | $0.00 | $-74.56M | — | — | — |
| 2024 | $636000.00 | $-57.77M | 100.00% | -9,511.95% | -9,084.12% |
| 2025 | $858000.00 | $-8.98M | 89.28% | -3,270.86% | -1,046.39% |